<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of pitavastatin and pravastatin treatment on renal function was compared in type 2 diabetic patients with <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in a randomized, controlled, open-label, parallel and multi-centre study </plain></SENT>
<SENT sid="1" pm="."><plain>Type 2 diabetic patients with modest <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> (serum <z:chebi fb="0" ids="16737">creatinine</z:chebi> level &lt;1.4 mg/dl) accompanied by <z:mp ids='MP_0002871'>albuminuria</z:mp> (30-600 mg/g <z:chebi fb="0" ids="16737">creatinine</z:chebi>) were randomly assigned to receive 2 mg of pitavastatin (n = 44) or 10 mg of pravastatin (n = 43) for 12 months </plain></SENT>
<SENT sid="2" pm="."><plain>At 12 months, pitavastatin significantly reduced urinary albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio than pravastatin in subjects with macroalbuminuria (-67.2% vs. +14.5%, p = 0.0040), but not in subjects with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>There was no significant difference in the change in estimated glomerular filtration rate between the two groups </plain></SENT>
<SENT sid="4" pm="."><plain>Pitavastatin is more effective than pravastatin for the reduction of <z:mp ids='MP_0002871'>albuminuria</z:mp> in type 2 diabetic patients with early stage of diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
</text></document>